IP Library › Granted Patent US 9,211,177
Granted Patent B2
US 9,211,177 · App. 14/532,576 · Granted Dec 15, 2015

Implantable article and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,211,177
App. No.
14/532,576
Granted
Dec 15, 2015
Kind
B2
Abstract

An implantable article and method are disclosed for treating pelvic floor disorders such as vaginal vault prolase. A surgical kit useful for performing a surgical procedure such as a sacral colpopexy is also described.

Claims (24)

1. An implant system, comprising:

an implant including a first tissue engagement portion, a second tissue engagement, and a base portion extending along a length in direction away from the first and second tissue engagement portions, wherein a width of the base portion is less than a width of the first tissue engagement portion and the second tissue engagement portion; and

at least one delivery device including a needle portion and a handle portion.

2. The implant system of claim 1 , wherein a width of the base portion decreases along the length.

3. The implant system of claim 1 , further including a polymeric fabric and a coating.

4. The implant system of claim 3 , wherein the coating is silicone.

5. The implant system of claim 1 , wherein the implant is sized and shaped to extend from a sacrum to vaginal tissue of a patient.

6. The implant system of claim 1 , wherein the base portion is sized and shaped to extend to a sacrum of a patient.

7. The implant system of claim 1 , wherein the first and second tissue engagement portions are sized and shaped to affix to a portion of the vagina.

8. The implant system of claim 7 , wherein the first and second tissue engagement portions are sized and shaped to affix to an apex of the vagina.

9. The implant system of claim 1 , wherein the implant is provided in a generally Y-shaped configuration.

10. The implant system of claim 1 , wherein the needle portion of the delivery device is straight.

11. An implant system, comprising:

an implant including a first tissue engagement portion, a second tissue engagement, and a base portion extending along a length in direction away from the first and second tissue engagement portions to define a generally Y-shaped construct; and

at least one delivery device including a needle portion and a handle portion.

12. The implant system of claim 11 , wherein at least a portion of the implant is resorbable.

13. The implant system of claim 11 , wherein at least the first and second tissue engagement portions are constructed of a mesh material.

14. The implant system of claim 11 , wherein at least the base portion is constructed of a mesh material.

15. The implant system of claim 11 , wherein the base portion includes a width less than a width of the first tissue engagement portion and a width of the second tissue engagement portion.

16. The implant system of claim 11 , wherein at least a portion of the implant includes indicia to indicate proper orientation of the implant.

17. The implant system of claim 11 , wherein the base portion is sized and shaped to extend to a sacrum of a patient.

18. The implant system of claim 11 , wherein the first and second tissue engagement portions are sized and shaped to affix to an apex of the vagina.

19. The implant system of claim 18 , wherein the first tissue engagement portion is sized and shaped to affix to a posterior side of the apex.

20. The implant system of claim 18 , wherein the second tissue engagement portion is sized and shaped to affix to an anterior side of the apex.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: ASTORA WOMEN'S HEALTH, LLC
To: STASKIN, DAVID, MD, DR
Reel/Frame 045605/0796 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →